IPP Bureau
Dr. Jitendra Singh conferred Lifetime Achievement Award
By IPP Bureau - August 01, 2024
Dr. Jitendra Singh’s pioneering work on “Stress Diabetes in Kashmiri Migrants” was hailed by the World Health Organization
Dr. Agarwals Eye Hospital posts standalone Q1 FY25 PAT higher at Rs. 14.11 Cr
By IPP Bureau - August 01, 2024
Dr. Agarwals Eye Hospital has reported total income of Rs. 100.42 crores during the period ended June 30, 2024
Ajanta Pharma posts Q1 FY25 consolidated PAT at Rs. 245.77 Cr
By IPP Bureau - August 01, 2024
Ajanta Pharma has reported total income of Rs. 1,171.39 crores during the period ended June 30, 2024
Bayer submits NDA to USFDA for elinzanetant for the treatment of VMS associated with menopause
By IPP Bureau - August 01, 2024
The New Drug Application (NDA) includes data from the Phase III studies OASIS 1, 2 and 3 - showing elinzanetant significantly reduced the frequency and severity of moderate to severe vasomotor symptoms over 12 weeks compared to placebo
Fredun Pharmaceuticals Q1 FY25 PAT drops QoQ to Rs. 4.12 Cr
By IPP Bureau - July 31, 2024
Fredun Pharmaceuticals has reported total income of Rs. 78.81 crores during the period ended June 30, 2024
Themis Medicare posts Q1 FY25 consolidated PAT higher at Rs. 24.68 Cr
By IPP Bureau - July 31, 2024
Themis Medicare has reported total income of Rs. 123.95 crores during the period ended June 30, 2024
American Oncology Institute (AOI) Nagpur conducts two consecutive successful bone marrow transplants
By IPP Bureau - July 31, 2024
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
Granules India posts Q1 FY25 consolidated PAT higher at Rs. 134.64 Cr
By IPP Bureau - July 31, 2024
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
Boehringer Ingelheim acquires Nerio Therapeutics for US$ 1.3bn
By IPP Bureau - July 31, 2024
Boehringer Ingelheim aims to develop this program as a potential key centerpiece component for its immuno-oncology portfolio
Barentz acquires Anshul Life Sciences to strengthen India portfolio
By IPP Bureau - July 31, 2024
The acquisition will further strengthen Barentz’ position in India creating a leading life science distribution platform
Zydus receives approval from COFEPRIS to market? Mamitra to treat various cancers
By IPP Bureau - July 31, 2024
The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2
Jagat Pharma launches isotine eye gummies for enhanced vision support
By IPP Bureau - July 31, 2024
These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development
Fischer MVL and Bio Angle Vacs partner to launch livestock and aquaculture vaccines to India
By IPP Bureau - July 31, 2024
BAV has revolutionized the animal vaccination industry with its ground-breaking delivery methods that prioritize quality, safety, and efficacy
GSK’s RSV vaccine ‘Arexvy’ receives positive European Medicines Agency’s CHMP opinion for adults aged 50-59
By IPP Bureau - July 30, 2024
Decision on EU marketing authorisation for this population expected by September 2024
Dr. Reddy's receives positive CHMP opinion from EMA for its proposed Rituximab biosimilar
By IPP Bureau - July 30, 2024
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
